Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc in HIV-1 infected children
NCT00791700Phase 2Unknown
- Sponsor
- ViiV Healthcare
- Start
- Apr 2009
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Status: unknown.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00791700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00791700.